Bioabsorbable metal stents for percutaneous treatment of critical recoarctation of the aorta in a newborn.
In neonates and infants with critical aortic coarctation, balloon angioplasty is considered for rescue therapy of heart failure. The use of conventional stents is limited because of further vessel growth, the need of redilation, and later surgical removal. However, a novel bioabsorbable magnesium stent (AMS) might overcome such restrictions of vessel stenting in newborns. Presented is the first use of an AMS for acute treatment of a newborn with severely impaired heart function due to a long segment recoarctation after a complex surgical repair. We hypothesize that bioabsorbable stents will dramatically change the treatment of coarctation and recoarctation in newborns.
Pediatric Heart Center, Justus-Liebig University Giessen, Giessen, Germany. Dietmar.Schranz@paediat.med.uni-giessen.de
Dietmar
D
Schranz
Peter
P
Zartner
Ina
I
Michel-Behnke
Hakan
H
Akintürk
D020341:Absorbable Implants; D001017:Aortic Coarctation / Q000175:diagnosis / Q000601:surgery / Q000628:therapy*; D006328:Cardiac Catheterization / Q000379:methods; D003287:Contrast Media; D017023:Coronary Angiography; D004452:Echocardiography; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D008670:Metals; D019233:Retreatment; D015607:Stents
D003287:Contrast Media; D008670:Metals